On Tuesday, Shares of Kinross Gold Corporation (USA)(NYSE:KGC), subtract -13.11% and closed at $3.58 in the last trading session. The last trading range of the stock ranges between $3.56 and $3.95. Kinross Gold Corporation (TSX:K.TO) (KGC) is happy to declare that it has agreed to a new three-year collective labour agreement (CLA) with unionized employees at its Tasiast mine in Mauritania.
As formerly declared in its Q2 2016 results news release, the Company and the Government of Mauritania have also agreed to a “Mauritanization” plan to increase the number of local workers at Tasiast, a requirement under Mauritanian law. Tasiast resumed normal mining and processing activities in mid-August after resolving the expatriate work permit issue, which was part of the Mauritanization plan agreement.
Gilead Sciences, Inc. (NASDAQ:GILD), dropped -1.01% and closed at $77.24 in the last trading session. The last trading range of the stock ranges between $77.12 and $78.42. The company’s Market capitalization is $100.53 Billion with the total Outstanding Shares of 1.32 Billion. Gilead Sciences, Inc. (GILD) recently declared it has reached a partnership with the World Health Organization (WHO) to provide $20 million in funding and drug donations over five years to expand access to diagnostic services and treatment for visceral leishmaniasis (VL). As part of this collaboration, Gilead will donate 380,000 vials of AmBisome® (amphotericin B liposome for injection) to meet the needs of WHO to treat VL in key endemic countries, counting Bangladesh, Ethiopia, India, Nepal, South Sudan and Sudan.
VL, also known as kala-azar, is the world’s second-deadliest parasitic infectious disease and affects up to 300,000 people annually in resource-limited countries.
“This new partnershipcomes at the right time as we gear up to support endemic countries in the Eastern Africa sub-region and South-East Asia to eliminate visceral leishmaniasis as a public health problem by or before 2020,” said Dr. Ren Minghui, WHO Assistant Director-General for HIV/AIDS, Malaria and Neglected Tropical Diseases. “During the past five years, AmBisome, donated by Gilead, allowed many countries in the Region highly endemic for VL to implement WHO’s recommended first line treatment, benefitting thousands of people.”
Exxon Mobil Corporation (NYSE:XOM), subtract -0.92% and closed at $86.25 in the last trading session. The last trading range of the stock ranges between $86.07 and $87.50. During the 52-week trading session the minimum price at which share price traded, registered at $71.55 and reached to max level of $95.55. Jack Balagia, vice president and general counsel, Exxon Mobil Corporation (XOM), has declared his intention to retire effective Nov. 1, 2016, after more than 18 years of service.
It is anticipated that the board of directors will elect Randall Ebner as vice president and general counsel, Exxon Mobil Corporation. Ebner is presently assistant general counsel, Exxon Mobil Corporation.
A native of Austin, Texas, Balagia joined the Exxon Company, USA Law Department in May 1998 in Houston as counsel in the litigation group. He became coordinator for Upstream litigation in 1999 and assistant general counsel in 2004. He was named to his current position in March 2010.
Balagia, who will reach the mandatory retirement age of 65 in October, is a member of numerous professional associations, counting a member of the Board of Directors of the National Center for State Courts, co-chair of the Civil Justice Reform Group, and vice chair of the University of Texas Law School Foundation Board of Trustees.